View random article

Hallucinogenics to Remedy Depression: Trippin'

Hallucinogenics to remedy depression is a little "trippin'." But retired clinical psychologist Clark Martin of Vancouver, Washington, has turned to psychedelics to remedy depression after traditional treatments brought him no relief. Martin suffers from kidney cancer and a resulting depression that is largely untreatable. Martin was in tremendous pain until a psychedelic experience helped him. Traditional pharmacuticals had not alleviated the effects of chemotherapy or the severe depression which accompanied Martin's cancer diagnosis so he turned to an experimental study involving hallucinogenics. At the age of 65, Martin travelled to Johns Hopkins Medical School and participated in his first psychedelic experience after taking psilocybin, the pyschoactive ingredient in "magic" mushrooms. Though rigorous redtape, strict guidelines, and close monitoring of patients, doctors at John Hopkins earned the permission to delve into psychedelics to develop non-traditional treatments for a variety of disorders.

Martin stated in a recent interview that "It was a whole personality shift for me. I wasn’t any longer attached to my performance and trying to control things. I could see that the really good things in life will happen if you just show up and share your natural enthusiasms with people." Lying on a couch under the strict supervision of doctors, complete with an eye mask, Martin experienced in a six hour process: "All of a sudden, everything familiar started evaporating. Imagine you fall off a boat out in the open ocean, and you turn around, and the boat is gone. And then the water’s gone. And then you’re gone.”

The staff from Johns Hopkins and researchers from around the globe will gather in San Jose, California to attend the largest conference on psychedelics to be held on U.S. soil in over 40 years. The agenda includes studies on psilocybin and other pschedelics for the treatment of depression, obsessive-compulsive disorder, end of life anxiety, effects on cancer patients undergoing treatment, post traumatic stress disorder, and of course, drug and alcohol addiction.

Featured in Health